FUNDACIO INSTITUT D'INVESTIGACIO BIOMEDICA DE BELLVITGE - Spain 

Ranking results:

Past rankings:

2020
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
2019
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
2018
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:700-800
2015
Criterium:Position:
Overall Score:400-500
Total Project Funding per Partner:700-800
Total Number of Projects:700-800
Networking Rank (Reputation):> 1000
Partner Constancy:600-700
Project Leadership Index:200-300
2012
Criterium:Position:
Overall Score:900-1000
Networking Rank (Reputation):> 1000
Networking Rank (Reputation):> 1000

Ranking timeline:

Project Participation Performance(2012-01-01 - 2025-12-31 ):

Total Project Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:

Leadership:

Total number of projects: 38
As coordinator: 3
As participant: 17
Sole participant: 18
Coordinator / Participant Ratio: 0.18*

*Ratio includes only projects with > 2 partners

Summary:

Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2023 0 8.857.813 0 1
2022 290.632 14.731.357 290.632 2 2
2021 2.481.225 20.306.836 2.504.187 4 4
2020 321.865 0 321.865 2
2019 170.122 0 170.122 1
2018 644.486 0 644.486 4
2017 3.831.958 0 743.619 1
2016 158.122 1.999.960 2.158.082 1 1
2015 4.045.426 7.411.340 1.175.197 2 2
2014 352.176 0 352.176 1
2013 0 13.900.091 1.557.949 3
2012 3.512.185 18.340.793 1.835.438 3 4
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:

Institution:Projects [No]:
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE6
IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE4
INSTITUT CATALA DE LA SALUT4
KAROLINSKA INSTITUTE4
FUNDACIO INSTITUT DE RECERCA BIOMEDICA3
INSTITUT CATALA D'ONCOLOGIA3
MEDIZINISCHE UNIVERSITAET WIEN3
UNIVERSITA DEGLI STUDI DI TORINO3
UNIVERSITY COLLEGE LONDON3
UNIVERSITY OF HELSINKI3
AARHUS KOMMUNEHOSPITAL AARHUS UNIVERSITY HOSPITAL2
ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN AMSTERDAM2
ASSISTANCE PUBLIQUE HOPITAUX DE PARIS2
BOEHRINGER INGELHEIM PHARMA GMBH &CO KG2
DIAGENODE2
FOUNDATION FOR RESEARCH AND TECHNOLOGY HELLAS2
FUNDACIO PRIVADA CLINIC PER A LA RECERCA BIOMEDICA2
GOETEBORGS UNIVERSITET2
KATHOLIEKE UNIVERSITEIT LEUVEN2
LUDWIG MAXIMILIANS UNIVERSITAET MUENCHEN2
NARODOWY INSTYTUT ONKOLOGII IM MARII SKLODOWSKIEJCURIE PANSTWOWY INSTYTUT BADAWCZY2
TARTU ULIKOOL2
TECHNION ISRAEL INSTITUTE OF TECHNOLOGY2
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD2
THE REGENTS OF THE UNIVERSITY OF CALIFORNIA2
THE UNIVERSITY OF EDINBURGH2
UNIVERSITA DEGLI STUDI DI PERUGIA2
ACADEMIC MEDICAL CENTRE AMSTERDAM1
ACADEMISCH ZIEKENHUIS GRONINGEN1
ACCELOPMENT SCHWEIZ1
AGENZIA NAZIONALE PER I SERVIZI SANITARI REGIONALI1
AMC MEDICAL RESEARCH BV1
APPLIED RESEARCH USING OMIC SCIENCES SL1
ASOCIACION PARA LA GESTION DEL CENTRO EUROPEO DE EMPRESAS E INNOVACION DE BURGOS1
ASOCIATIA MELANOM ROMANIA1
ATHENA TECH SL1
AVANTEA1
AVANTICELL SCIENCE1
AZIENDA OSPEDALIERA DI PADOVA1
AZIENDA SOCIOSANITARIA TERRITORIALE FATEBENEFRATELLI SACCO1
BATAVIA BIOSERVICES BV1
BIOCOMUNICAT1
BIOLUTION1
BIOMAX INFORMATICS1
BIOMEDICAL SCIENCES RESEARCH CENTER ALEXANDER FLEMING1
BIOMERIEUX1
CANCEROPOLE PACA1
CENTRE EUROPEEN DE RECHERCHE EN BIOLOGIE ET MEDECINE1
CENTRE HOSPITALIER UNIVERSITAIRE DE NANTES1
CENTRE HOSPITALIER UNIVERSITAIRE VAUDOIS1
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE1
CENTRE REGIONAL DE LUTTE CONTRE LE CANCER HENRI BECQUEREL ROUEN1
CENTRO DE INVESTIGACION BIOMEDICA EN RED1
CENTRO HOSPITALAR E UNIVERSITARIO DE COIMBRA EPE1
CENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES CARLOS III1
CHARITE UNIVERSITAETSMEDIZIN BERLIN1
CHROMACURE1
CLC BIO1
CONSIGLIO NAZIONALE DELLE RICERCHE1
CRUCELL HOLLAND B V1
DEUTSCHES KREBSFORSCHUNGSZENTRUM1
DEUTSCHES PRIMATENZENTRUM1
DIGESTIVE CANCERS EUROPE DICE1
DIGNA BIOTECH SL1
DUBLIN CITY UNIVERSITY1
EUROPEAN SOCIETY OF ANAESTHESIOLOGY AND INTENSIVE CARE AISBL1
EVOTEC SAS1
F4PHARMA GES M B H1
FONDATION DU CENTRE PLURIDISCIPLINAIRE D'ONCOLOGIE1
FONDAZIONE 1563 PER L'ARTE E LA CULTURA DELLA COMPAGNIA DI SAN PAOLO1
FONDAZIONE IRCCS ISTITUTO NAZIONALE DEI TUMORI1
FONDAZIONE ISTITUTO ITALIANO DI TECNOLOGIA1
FONDAZIONE POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI IRCCS1
FORSCHUNGSINSTITUT FUR MOLEKULARE PATHOLOGIE GESELLSCHAFT MBH1
FORSCHUNGSVERBUND BERLIN EV1
FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E V1
FUNDACIO HOSPITAL UNIVERSITARI VALL D'HEBRON INSTITUT DE RECERCA1
FUNDACIO INSTITUT DE RECERCA CONTRA LA LEUCEMIA JOSEP CARRERAS1
FUNDACIO PRIVADA INSTITUT D'INVESTIGACIO ONCOLOGICA DE VALLHEBRON1
FUNDACION DE LA COMUNIDAD VALENCIANA CENTRO DE INVESTIGACION PRINCIPE FELIPE1
FUNDACION ESADE1
FUNDACION INSTITUTO DE ESTUDIOS DE CIENCIAS DE LA SALUD DE CASTILLA Y LEON1
FUNDACION PARA LA INVESTIGACION BIOMEDICA DEL HOSPITAL GREGORIO MARANON1
FUNDACION PARA LA INVESTIGACION BIOMEDICA DEL HOSPITAL UNIVERSITARIO RAMON Y CAJAL1
FUNDACION PUBLICA ANDALUZA PARA LAGESTION DE LA INVESTIGACION EN SALUD DE SEVILLA1
GALAPAGOS1
GDANSKI UNIWERSYTET MEDYCZNY1
GENXPRO1
GLSMED LEARNING HEALTH1
HEINRICHHEINEUNIVERSITAET DUESSELDORF1
HOSPITAL CLINIC DE BARCELONA1
HOSPITAL SANT JOAN DE DEU1
IBM ISRAEL SCIENCE AND TECHNOLOGY1
IDRYMA IATROVIOLOGIKON EREUNON AKADEMIAS ATHINON1
IFOM FONDAZIONE ISTITUTO FIRC DI ONCOLOGIA MOLECOLARE1
INSTITUT CLINIQUE DE LA SOURIS1
INSTITUT CURIE1
INSTITUT DE INVESTIGACIO EN CIENCIES DE LA SALUT GERMANS TRIAS I PUJOL1
INSTITUT NATIONAL DE RECHERCHE POUR L'AGRICULTURE L'ALIMENTATION ET L'ENVIRONNEMENT1
INSTITUT PASTEUR1

Constancy:

Total number of partners: 244
Partner loyalty:
Frequent Partner: (> 2 projects): 36
Rare Partner: 208
Frequent / Rare Partner Ratio: 0.17

Project overview:

Start dateProjectacronymrolefundingpartners
2023-01-01Discovering the causes of three poorly understood cancers in Europe DISCERNparticipant8.857.81320
2022-12-01Novel health care strategies for melanoma in children, adolescents and young adults MELCAYAparticipant8.013.21925
2022-09-01Polymeric cell-laden vascular graft for blood vessel mimicking in tissue engineering applications STEMCEDIFcoordinator129.6991
2022-06-01The human genetic and immunological determinants of the clinical manifestations of SARS-CoV-2 infection: Towards personalised medicine UNDINEparticipant6.718.13921
2022-02-14Pseudohypoxia-mediated cardiac regeneration PhyCaRcoordinator160.9321
2021-09-01Single cell tracking of malignant transformation in GATA2 deficiency scGATA2trackcoordinator160.9321
2021-08-01Biomarker and AI-supported FX06 therapy to prevent progression from mild and moderate to severe stages of COVID-19 COVendparticipant9.994.97818
2021-06-01Remote Ischemic Conditioning in Lymphoma Patients Receiving Anthracyclines. RESILIENCEparticipant5.998.38818
2021-06-01Characterization of the gene and protein networks regulated by Staufen 2 in neurogenesis and their alterations in AD NEUROSTADcoordinator172.9321
2021-03-01Deconstructing the evolution of metastasis Evometparticipant4.014.43515
2021-03-01Paths to Succesful Innovations ISPASparticipant299.0367
2021-03-01Regeneration of Sinusoidal niches to preserve hematopoiesis after chemotherapy on Ageing ReSinAgecoordinator1.997.3601
2021-02-01A Human Neural Platform for Assaying Antigen-Antibody Interactions for Autoimmune Encephalitis NeurAntigencoordinator150.0001
2020-09-01Genetically modified organoids for genetic variant interpretation in colorectal cancer Organ-VIPcoordinator160.9321
2020-03-31Role of the SWI/SNF complex in the Androgen Receptor cistrome regulation RegARciscoordinator160.9321
2019-01-02Identification of a novel function of lysosomes in mitosis for cancer therapy M-Lysosomescoordinator170.1221
2018-09-05DNA MEthylation for HPV-related disease among women living with HIV MEsHHcoordinator158.1221
2018-09-03Human gut Microbiome, gene Expression and Colorectal Cancer: Assigning causal roles from a novel Mendelian randomization perspective. MECoCaMcoordinator158.1221
2018-09-01Activation of PI3K signalling in the pathogenesis of Vascular Anomalies PI3K-VAscoordinator158.1221
2018-04-01Personalized oncology for refractory and relapsed lymphoma using humanized patient derived othotopic xenografts (ImmunePDOX) PORTALcoordinator170.1221
2017-09-01Targeting the metabolism-immune system connections in Cancer META-CANcoordinator3.831.95820
2016-10-01Pleiotropic treatment of cancer: RANK inhibitors targeting cancer stem cells and immunity PLEIO-RANKparticipant1.999.9601
2016-03-01Identification and Characterization of Cis-Regulatory ModuleDysfunction in Rett Syndrome with ROQ-WACh ROQ-WAChcoordinator158.1221
2015-11-01Deciphering PI3K biology in health and disease Phdcoordinator3.896.14813
2015-10-01Endoplasmic Reticulum Stress in Health and Disease TRAIN-ERSparticipant3.628.75712
2015-02-01Development of a ncRNA DNA Methylation Kit for the Diagnosis of Cancer of Unknown Primary EPICUPcoordinator149.2781
2015-01-01Chromatin Dynamics in Development and Disease Chromatin3Dparticipant3.782.58312
2014-04-23Crosstalk between microRNAs and epigenetics in melanocyte differentiation: A new approach to unravel the complexity of melanoma progression and metastasis EPIMIRMELcoordinator352.1761
2013-09-01Defining the role of xeno-directed and autoimmune events in patients receiving animal-derived bioprosthetic heart valves TRANSLINKparticipant5.996.97113
2013-03-01Epigenetic Training Network - Innovative techniques and models to understand epigenetic regulation in the pathogenesis of common diseases EPITRAINparticipant3.816.5486
2013-01-01Vascular Endothelial interactionS and SpEciaLization VESSELparticipant4.086.5729
2012-10-01STRATEGY TO INHIBIT TGF-Beta IN LIVER DISEASE IT-LIVERcoordinator3.312.18511
2012-10-01"User-driven Development of Statistical Methods for Experimental Planning, Data Gathering, and Integrative Analysis of Next Generation Sequencing, Proteomics and Metabolomics data" STATEGRAparticipant5.998.57511
2012-04-01ADenoViruses as novel clinical treatments ADVanceparticipant3.861.45013
2012-03-01The Role of the RPL11/p53 Checkpoint in the Development and Treatment of DBA DBA-Checkpointscoordinator100.0001
2012-01-01Modulation of AMPA receptor properties by auxiliary subunits MOAMAUXcoordinator100.0001
2012-01-01Mechanisms of prevention of type 2 diabetes by lifestyle intervention in subjects with pre-diabetes or at high-risk for progression DEXLIFEparticipant5.486.63110
2012-01-01Pathways common to brain development and ageing: defining strategies for preventive therapy and diagnostics DEVELAGEparticipant2.994.1379